Adenosine dysfunction in astrogliosis: Cause for seizure generation?

Neuron Glia Biology

Volumn 3, Issue 4, 2007, Pages 353-366

  Li, Tianfu ^a   Quan Lan, Jing ^a   Fredholm, Bertil B ^b   Simon, Roger P ^a   Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

A1 receptor; Astrocyte; Epileptogenesis; Kainic acid; Status epilepticus

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONTROLLED STUDY; EPILEPTOGENESIS; FOREBRAIN; MALE; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; UPREGULATION;

MUS; MUS MUSCULUS;

EID: 46749132311     PISSN: 1740925X     EISSN: 17410533     Source Type: Journal    
DOI: 10.1017/S1740925X0800015X     Document Type: Article

References (67)

1. Angelatou F., Pagonopoulou O., Maraziotis T., Olivier A., Villemeure J.G., Avoli M. et al. (1993) Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study. Neuroscience Letters 163, 11-14.
2. Arch J.R. and Newsholme E.A. (1978) Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochemical Journal 174, 965-977.
3. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E. and Young J.D. (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Archive European Journal of Physiology 447, 735-743.
4. Boison D. (2006) Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends in Pharmacological Sciences 27, 652-658.
5. Boison D. (2007a) Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Neurodegenerative Diseases 4, 28-33.
6. Boison D. (2007b) Adenosine as a modulator of brain activity. Drug News and Perspectives 20, 607-611.
7. Boison D. (2007c) Cell and gene therapies for refractory epilepsy. Current Neuropharmacology 5, 115-125.
8. Boison D. (2008a) Adenosine as a neuromodulator in neurological diseases. Current Opinion in Pharmacology 8, 2-7.
9. Boison D. (2008b) The adenosine kinase hypothesis of epileptogenesis. Progress in Neurobiology 84, 249-262.
10. Boison D., Scheurer L., Zumsteg V., Rülicke T., Litynski P., Fowler B. et al. (2002) Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proceedings of the National Academy of Sciences of the U.S.A. 99, 6985-6990.
11. Bontemps F., Van den Berghe G. and Hers H.G. (1983) Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proceedings of the National Academy of Sciences of the U.S.A. 80, 2829-2833.
12. Chin J.H., Wiesner J.B. and Fujitaki J. (1995) Increase in adenosine metabolites in human cerebrospinal fluid after status epilepticus. Journal of Neurology, Neurosurgery, and Psychiatry 58, 513-514.
13. Cunha R.A. (2008) Different cellular sources and different roles of adenosine: A(1) receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A(2A) receptor-mediated facilitation of plasticity. Neurochemistry International 52, 65-72.
14. Dragunow M. (1991) Adenosine and seizure termination. Annals of Neurology 29, 575.
15. Dragunow M., Goddard G.V. and Laverty R. (1985) Is adenosine an endogenous anticonvulsant? Epilepsia 26, 480-487.
16. Duffy S. and MacVicar B.A. (1999) Modulation of neuronal excitability by astrocytes. Advances in Neurology 79, 573-581.
17. Dunwiddie T.V. (1980) Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 21, 541-548.
18. Dunwiddie T.V. (1999) Adenosine and suppression of seizures. Advances in Neurology 79, 1001-1010.
19. Dunwiddie T.V. and Masino S.A. (2001) The role and regulation of adenosine in the central nervous system. Annual Review in Neuroscience 24, 31-55.
20. Dunwiddie T.V. and Worth T. (1982) Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. Journal of Pharmacology and Experimental Therapeutics 220, 70-76.
21. During M.J. and Spencer D.D. (1992) Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Annals of Neurology 32, 618-624.
22. Fedele D.E., Gouder N., Güttinger M., Gabernet L., Scheurer L., Rulicke T. et al. (2005) Astrogliosis in epilepsy leads to overexpression of adenosine kinase resulting in seizure aggravation. Brain 128, 2383-2395.
23. Fedele D.E., Koch P., Brüstle O., Scheurer L., Simpson E.M., Mohler H. et al. (2004) Engineering embryonic stem cell derived glia for adenosine delivery. Neuroscience Letters 370, 160-165.
24. 1 receptors are crucial in keeping an epileptic focus localized. Experimental Neurology 200, 184-190.
25. Fields R.D. and Burnstock G. (2006) Purinergic signalling in neuronglia interactions. Nature Review Neuroscience 7, 423-436.
26. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P. and Vaugeois J.M. (2005a) Adenosine and brain function. International Review in Neurobiology 63, 191-270.
27. Fredholm B.B., Chen J.F., Masino S.A. and Vaugeois J.M. (2005b) Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs. Annual Review in Pharmacology and Toxicology 45, 385-412.
28. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N. and Linden J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Reviews 53, 527-552.
29. Glass M., Faull R.L., Bullock J.Y., Jansen K., Mee E.W., Walker E.B. et al. (1996) Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Research 710, 56-68.
30. 1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44, 877-885.
31. Gouder N., Scheurer L., Fritschy J.-M. and Boison D. (2004) Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. Journal of Neuroscience 24, 692-701.
32. Gray J.H., Owen R.P. and Giacomini K.M. (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Archive European Journal of Physiology 447, 728-734.
33. 1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Experimental Neurology 193, 53-64.
34. Halassa M.M., Fellin T. and Haydon P.G. (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends in Molecular Medicine 13, 54-63.
35. Haydon P.G. and Carmignoto G. (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiological Reviews 86, 1009-1031.
36. Henshall D.C. and Simon R.P. (2005) Epilepsy and apoptosis pathways. Journal of Cerebral Blood Flow and Metabolism 25, 1557-1572.
37. Huber A., Padrun V., Deglon N., Aebischer P., Mohler H. and Boison D. (2001) Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proceedings of the National Academy of Sciences of the U.S.A. 98, 7611-7616.
38. Iwasato T., Nomura R., Ando R., Ikeda T., Tanaka M. and Itohara S. (2004) Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice. Genesis 38, 130-138.
39. Johansson B., Halldner L., Dunwiddie T.V., Masino S.A., Poelchen W., Gimenez-Llort L. et al. (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proceedings of the National Academy of Sciences of the U.S.A. 98, 9407-9412.
40. Kochanek P.M., Vagni V.A., Janesko K.L., Washington C.B., Crumrine P.K., Garman R.H. et al. (2006) Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism 26, 565-575.
41. Kunz W.S. (2002) The role of mitochondria in epileptogenesis. Current Opinion in Neurology 15, 179-184.
42. Lee K.S., Schubert P. and Heinemann U. (1984) The anticonvulsive action of adenosine: a postsynaptic, dendritic action by a possible endogenous anticonvulsant. Brain Research 321, 160-164.
43. Li T., Ren G., Lusardi T., Wilz A., Lan J.Q., Iwasato T. et al. (2008) Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. Journal of Clinical Investigation 118, 571-582.
44. Li T., Steinbeck J.A., Lusardi T., Koch P., Lan J.Q., Wilz A. et al. (2007) Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 130, 1276-1288.
45. Loscher W., Gernert M. and Heinemann U. (2008) Cell and gene therapies in epilepsy - promising avenues or blind alleys? Trends in Neurosciences 210, 624-637.
46. Meyer P.T., Elmenhorst D., Boy C., Winz O., Matusch A., Zilles K. et al. (2007) Effect of aging on cerebral A(1) adenosine receptors: A [F-18] CPFPX PET study in humans. Neurobiology of Aging 28, 1914-1924.
47. Mimouni M., Bontemps F. and Van den Berghe G. (1994) Kinetic studies of rat liver adenosine kinase. Journal of Biological Chemistry 269, 17820-17825.
48. Pan J.W., Kim J.H., Cohen-Gadol A., Pan C., Spencer D.D. and Hetherington H.P. (2005) Regional energetic dysfunction in hippocampal epilepsy. Acta Neurologica Scandinavica 111, 218-224.
49. Pascual O., Casper K.B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J.Y. et al. (2005) Astrocytic purinergic signaling coordinates synaptic networks. Science 310, 113-116.
50. Pignataro G., Maysami S., Studer F.E., Wilz A., Simon R.P. and Boison D. (2008) Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. Journal of Cerebral Blood Flow and Metabolism 28, 17-23.
51. Pignataro G., Simon R.P. and Boison D. (2007) Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. Journal of Cerebral Blood Flow and Metabolism 27, 1-5.
52. Raedt R., Van Dycke A., Vonck K. and Boon P. (2007) Cell therapy in models for temporal lobe epilepsy. Seizure - European Journal of Epilepsy 16, 565-578.
53. Ren G., Li T., Lan J.Q., Wilz A., Simon R.P. and Boison D. (2007) Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Experimental Neurology 208, 26-37.
54. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W. et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
55. Sebastiao A.M. and Ribeiro J.A. (2000) Fine-tuning neuromodulation by adenosine. Trends in Pharmacological Sciences 21, 341-346.
56. Shetty A.K. and Hattiangady B. (2007) Concise review: Prospects of stem cell therapy for temporal lobe epilepsy. Stem Cells 25, 2396-2407.
57. Shinoda S., Schindler C.K., Meller R., So N.K., Araki T., Yamamoto A. et al. (2004) Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy. Journal of Clinical Investigation 113, 1059-1068.
58. Sisodiya S. (2007) Etiology and management of refractory epilepsies. Nature Clinical Practice Neurology 3, 320-330.
59. Studer F.E., Fedele D.E., Marowsky A., Schwerdel C., Wernli K., Vogt K. et al. (2006) Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 142, 125-137.
60. Tashiro A., Goldberg J. and Yuste R. (2002) Calcium oscillations in neocortical astrocytes under epileptiform conditions. Journal of Neurobiology 50, 45-55.
61. Tian G.F., Azmi H., Takano T., Xu Q.W., Peng W.G., Lin J. et al. (2005) An astrocytic basis of epilepsy. Nature Medicine 11, 973-981.
62. Togha M., Akhondzadeh S., Motamedi M., Ahmadi B. and Razeghi S. (2007) Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial. Archives of Medical Research 38, 313-316.
63. Vajda F.J.E. (2007) Pharmacotherapy of epilepsy: New armamentarium, new issues. Journal of Clinical Neuroscience 14, 813-823.
64. Williamson A., Patrylo P.R., Pan J., Spencer D.D. and Hetherington H. (2005) Correlations between granule cell physiology and bioenergetics in human temporal lobe epilepsy. Brain 128, 1199-1208.
65. Wu N.L. and Boison D. (2007) Adenosine kinase expression modulates expression of myelin proteolipid protein. The Open Neuroscience Journal 1, 15-19.
66. Yee B.K., Singer P., Chen J.F., Feldon J. and Boison D. (2007) Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. European Journal of Neuroscience 26, 3237-3252.
67. Zimmermann H. (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Archives of Pharmacology 362, 299-309.